dipyridamole has been researched along with Leukemia, Myeloid, Acute in 10 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole strongly inhibited spontaneous in vitro proliferation of peripheral blood mononuclear cells from patients with acute myelogenous leukaemia (n = 9), chronic myelogenous leukaemia in first chronic phase (n = 4) and blast phase (n = 1)." | 3.68 | Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cells. ( Bruserud, O, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pandyra, A | 1 |
| Mullen, PJ | 1 |
| Kalkat, M | 1 |
| Yu, R | 1 |
| Pong, JT | 1 |
| Li, Z | 1 |
| Trudel, S | 1 |
| Lang, KS | 1 |
| Minden, MD | 1 |
| Schimmer, AD | 1 |
| Penn, LZ | 1 |
| Drenberg, CD | 1 |
| Gibson, AA | 1 |
| Pounds, SB | 1 |
| Shi, L | 1 |
| Rhinehart, DP | 1 |
| Li, L | 1 |
| Hu, S | 1 |
| Du, G | 1 |
| Nies, AT | 1 |
| Schwab, M | 1 |
| Pabla, N | 1 |
| Blum, W | 1 |
| Gruber, TA | 1 |
| Baker, SD | 1 |
| Sparreboom, A | 1 |
| Babaoglu, MO | 1 |
| Karadag, O | 1 |
| Saikawa, Y | 1 |
| Altundag, K | 1 |
| Elkiran, T | 1 |
| Yasar, U | 1 |
| Bozkurt, A | 1 |
| Boccaccio, P | 1 |
| Ghio, R | 1 |
| Ratti, M | 1 |
| Casciaro, S | 1 |
| Rattenni, S | 1 |
| Sergnese, G | 1 |
| Bruserud, O | 2 |
| Pawelec, G | 1 |
| Nakai, K | 1 |
| Tajima, K | 1 |
| Kishimoto, Y | 1 |
| Katsura, K | 1 |
| Kawamura, M | 1 |
| Yamamoto, Y | 1 |
| Hanada, M | 1 |
| Zen, K | 1 |
| Amakawa, R | 1 |
| Fujimoto, M | 1 |
| Fukuhara, S | 1 |
| Carcassonne, Y | 1 |
| Gastaut, JA | 1 |
| Blanc, AP | 1 |
| Yang, JL | 1 |
| White, JC | 1 |
| Capizzi, RL | 1 |
| Nishino, T | 1 |
1 review available for dipyridamole and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
[Disseminated intravascular coagulation. II. Therapeutic problems].
Topics: Antifibrinolytic Agents; Antithrombin III Deficiency; Anuria; Aprotinin; Aspirin; Blood Transfusion; | 1982 |
9 other studies available for dipyridamole and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line | 2014 |
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
Topics: Animals; Antimetabolites, Antineoplastic; Child; CHO Cells; Cohort Studies; Cricetulus; Cytarabine; | 2017 |
Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.
Topics: Antimetabolites, Antineoplastic; Blood Cell Count; Chemical and Drug Induced Liver Injury; Cytarabin | 2004 |
Effects of dipyridamole and R-verapamil on in vitro proliferation of blast cells from patients with acute myelogenous leukaemia.
Topics: Adult; Aged; Blast Crisis; Cell Division; Dipyridamole; Dose-Response Relationship, Drug; Female; Gr | 1993 |
[Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
Topics: Adult; Aspirin; Bone Marrow Transplantation; Dipyridamole; Female; Humans; Leukemia, Myeloid, Acute; | 2000 |
Acute leukemia after prolonged immunosuppressive therapy for glomerulonephritis.
Topics: Adolescent; Alkylating Agents; Chlorambucil; Dipyridamole; Glomerulonephritis; Humans; Indomethacin; | 1978 |
Effect of dipyridamole, theophyllamine and verapamil on spontaneous in vitro proliferation of myelogenous leukaemia cells.
Topics: Aminophylline; Blast Crisis; Cell Division; Dipyridamole; Dose-Response Relationship, Drug; Drug Scr | 1992 |
Modulation of the cellular pharmacokinetics of ara-CTP in human leukemic blasts by dipyridamole.
Topics: Biological Transport; Cytarabine; Dipyridamole; Drug Interactions; Humans; Leukemia, Myeloid, Acute; | 1992 |
[Studies on platelet adhesiveness. II. On various diseases].
Topics: Adenosine; Arteriosclerosis; Dextrans; Diabetes Mellitus; Dipyridamole; Female; Fibrinolytic Agents; | 1970 |